TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
An 18-Month Double-Blind, Placebo-Controlled, Phase III, Trial With a 12-Month Interim Analysis of the Effect of Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
1 other identifier
interventional
2,532
9 countries
174
Brief Summary
This is an 18-month, double-blind, placebo-controlled, Phase III trial with a 12-month interim analysis of the effect of ALX1-11, recombinant human parathyroid hormone (1-84) (rhPTH \[1-84\]), on fracture incidence in women with postmenopausal osteoporosis, the TOP study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Apr 2000
Typical duration for phase_3
174 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 27, 2000
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 7, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
November 7, 2003
CompletedFirst Submitted
Initial submission to the registry
September 9, 2005
CompletedFirst Posted
Study publicly available on registry
September 15, 2005
CompletedMay 14, 2021
May 1, 2021
3.5 years
September 9, 2005
May 12, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Compare effects of 18 months of treatment with ALX1-11/placebo on the incidence of new and/or worsened thoracic and lumbar vertebral fractures in postmenopausal women with osteoporosis receiving calcium and vitamin D3 supplements
At Month 18
Secondary Outcomes (1)
Incidences of vertebral fractures at Month 12; hip and wrist fractures; and other clinical fractures.
At Month 12
Study Arms (2)
placebo
PLACEBO COMPARATORDaily subcutaneous injection into thigh or abdomen with 700 mg Calcium and 400 IU Vitamin D daily
PTH(1-84) 100 mcg
EXPERIMENTALSubcutaneous injection of PTH(1-84) with 700 mg Calcium and 400 IU Vitamin D daily
Interventions
Eligibility Criteria
You may qualify if:
- Women who are postmenopausal with at least one year since the last menstruation.
- Women who are 45-54 years of age with the following bone mineral density (BMD) and/or vertebral fracture:
- BMD 3.0 standard deviations (SDs) or more below peak bone mass of young females at the lumbar spine, femoral neck, or total hip; or
- BMD 2.5 SDs or more below peak bone mass of young females at the lumbar spine, femoral neck or total hip with the presence of a vertebral fracture verified by the central imaging organization before the patient is enrolled into the study.
- Women 55 or more years of age with the following BMD and/or vertebral fracture:
- BMD 2.5 SDs or more below peak bone mass of young females at the lumbar spine, femoral neck or total hip; or
- BMD 2.0 SDs or more below peak bone mass of young females at the lumbar spine, femoral neck or total hip with the presence of a vertebral fracture verified by the central imaging organization before the patient is enrolled into the study.
- The following types of vertebral fractures should not be considered for patient enrollment into this trial:
- Pathological fractures due to malignant disease or infection
- Fractures due to excessive trauma sufficient to cause a fracture in young individuals with normal bone mass
- Women with the ability to self-administer a daily injection or have a designee who will give the injections
- Women who are capable of understanding and giving written, voluntary informed consent before the clinical trial screening visit
You may not qualify if:
- A. Vertebral Deformity:
- Patient has 5 or more vertebral (thoracic and lumbar) deformities
- Patient has 2 or more lumbar vertebral deformities (L1 to L4)
- Severe lumbar scoliosis (\>15 degrees) which precludes a reliable evaluation of the dual x-ray absorptiometry (DXA)
- B. DXA Imaging:
- Inability to have a DXA scan performed.
- C. History or Concurrent Illness:
- Disorders of immunity
- Endocrine system
- Gastrointestinal system
- Kidney and collecting system
- Liver, biliary tract and pancreatic systems
- Musculoskeletal system
- Neoplasia
- Nervous system
- +56 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shirelead
Study Sites (174)
Capstone Clinical Trials
Birmingham, Alabama, 35205, United States
'The University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
'Rheumatology Associates of North Alabama
Huntsville, Alabama, 35801, United States
'Radiant Research - Phoenix
Phoenix, Arizona, 85013, United States
'Robin K. Dore, M.D., Inc.
Anaheim, California, 92801, United States
'Osteoporosis Medical Center
Beverly Hills, California, 90211, United States
'East Bay Clinical Trial Center
Concord, California, 94520, United States
'Loma Linda Osteoporosis Research Center
Loma Linda, California, 92354, United States
'The Foundation for Osteoporosis Research and Education
Oakland, California, 94612, United States
'Desert Medical Advances
Palm Desert, California, 92260, United States
'VA Palo Alto Health Care System
Palo Alto, California, 94304, United States
'Boling Clinical Trials
Rancho Cucamonga, California, 91730, United States
'Radiant Research - San Diego
San Diego, California, 92108, United States
'S.D. Arthritis & Osteoporosis Medical Clinic
San Diego, California, 92120, United States
'San Francisco General Hospital
San Francisco, California, 94110, United States
'Community Research Centers
Santa Ana, California, 92701, United States
'Denver Arthritis Clinic
Denver, Colorado, 80220, United States
'Colorado Center for Bone Research
Lakewood, Colorado, 80227, United States
'Longmont Medical Research Network
Longmont, Colorado, 80501, United States
'Northeast Clinical Research, LLC
Hamden, Connecticut, 06518, United States
'Georgetown University Medical Center
Washington D.C., District of Columbia, 20007, United States
'RASF - Clinical Research Center
Boca Raton, Florida, 33486, United States
'ICSL Clinical Studies
Fort Myers, Florida, 33907, United States
'The Center for Diabetes and Endocrine Care
Hollywood, Florida, 33021, United States
'Florida Wellcare Alliance
Inverness, Florida, 34452, United States
'Radiant Research - Lake Worth
Lake Worth, Florida, 33461, United States
'Osteoporosis Center University of Miami
Miami, Florida, 33136, United States
'Renstar Medical Group
Ocala, Florida, 34471, United States
'Diabetes and Endocrinology Treatment Center
Palm Beach Gardens, Florida, 33410, United States
'The Arthritis Center
Palm Harbor, Florida, 34684, United States
'The Centre for Arthritis and Rheumatic Diseases
South Miami, Florida, 33143, United States
'ICSL Clinical Studies
St. Petersburg, Florida, 33702, United States
'Radiant Research - Stuart & LakeWorth
Stuart, Florida, 34996, United States
'Palm Beach Research Center
West Palm Beach, Florida, 33409, United States
'The Emory Clinic
Atlanta, Georgia, 30322, United States
'Radiant Research
Honolulu, Hawaii, 96814, United States
'Intermountain Orthopaedics
Boise, Idaho, 83702, United States
'ICSL-Clinical Studies
Bloomington, Illinois, 61704, United States
Rush-Prebyterian-St.Luke's Medical Center
Chicago, Illinois, 60612, United States
'The University of Chicago
Chicago, Illinois, 60637, United States
'University Hospital & Outpatient Center
Indianapolis, Indiana, 46202, United States
'Mercy Arthritis and Osteoporosis Center
Des Moines, Iowa, 50322, United States
'Wichita Clinic
Wichita, Kansas, 67208, United States
'Ochsner Clinic
New Orleans, Louisiana, 70121, United States
'Maine Center for Osteoporosis Research & Education
Bangor, Maine, 04401, United States
'Bethesda Health Research Center
Bethesda, Maryland, 20817, United States
'The Osteoporosis and Clinical Trials Center
Cumberland, Maryland, 21502, United States
'Arthritis & Osteoporosis Center of Maryland
Frederick, Maryland, 21702, United States
'The Osteoporosis and Clinical Trials Center
Hagerstown, Maryland, 21740, United States
'The Center for Rheumatology and Bone Research
Wheaton, Maryland, 20902, United States
'Brigham & Women's Hospital
Boston, Massachusetts, 02115, United States
'Phase III Clinical Research
Fall River, Massachusetts, 02720, United States
'Osteoporosis Research & Treatment Center
Worcester, Massachusetts, 01605, United States
'Michigan Bone & Mineral Clinic
Detroit, Michigan, 48236, United States
'Desoto Family Medical Center
Olive Branch, Mississippi, 38654, United States
'St. John's Medical Research Group
Springfield, Missouri, 65807, United States
'VA Southern NV Healthcare Systems
Las Vegas, Nevada, 89106, United States
'Arthritis, Osteoporosis Muscle Skeletal Disease Center
Concord, New Hampshire, 03301, United States
'Comprehensive Clinical Research
Berlin, New Jersey, 08009, United States
'Anderson and Collins Clinical Research Inc.
South Plainfield, New Jersey, 07080, United States
'New Mexico Clinical Research and Osteoporosis Center
Albuquerque, New Mexico, 87106, United States
'Lovelace Scientific Resources
Albuquerque, New Mexico, 87108, United States
'Bone Mineral Research Center
Mineola, New York, 11501, United States
'Beth Israël Medical Center
New York, New York, 10003, United States
'College of Physicians and Surgeons, Columbia University
New York, New York, 10032, United States
'Rochester Clinical Research Inc.
Rochester, New York, 14609, United States
'Stony Brook Clinical Research Trials Center
Stony Brook, New York, 11794, United States
'Physicians Clinical Research Services
White Plains, New York, 10605, United States
'Carolina Bone and Joint - Charlotte
Charlotte, North Carolina, 28210, United States
'Duke University Medical Center
Durham, North Carolina, 27710, United States
'Odyssey Research Services
Bismarck, North Dakota, 58501, United States
Michael J. Lillestol
Fargo, North Dakota, 58103, United States
'Altru Health Systems/Altru Research Center
Grand Forks, North Dakota, 58201, United States
'Odyssey Research Services
Minot, North Dakota, 58701, United States
'Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
'David R. Mandel M.D. Inc.
Mayfield, Ohio, 44143, United States
'Oklahoma Center for Arthritis Therapy & Research, Inc.
Tulsa, Oklahoma, 74114, United States
'Osteoporosis Center
Medford, Oregon, 97504, United States
'Altoona Center for Clinical Research
Duncansville, Pennsylvania, 16635, United States
'Thomas Jefferson University
Philadelphia, Pennsylvania, 19131, United States
'University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
'Clinical Research Center of Reading LLP
West Reading, Pennsylvania, 19611, United States
'Radiant Research
Wyomissing, Pennsylvania, 19610, United States
'Rhode Island Hospital
Providence, Rhode Island, 02903, United States
'Roger Williams Medical Center
Providence, Rhode Island, 02908, United States
'Radiant Research
Anderson, South Carolina, 29621, United States
'Columbia Arthritis Center, PA
Columbia, South Carolina, 29204, United States
'Radiant Research
Greer, South Carolina, 29651, United States
'Rapid City Medical Center
Rapid City, South Dakota, 57701, United States
'Averna Research Institute
Sioux Falls, South Dakota, 57105, United States
'Brown Clinic
Watertown, South Dakota, 57201, United States
'Clinsearch
Chattanooga, Tennessee, 37404, United States
'Radiant Research/Dallas
Dallas, Texas, 75235, United States
'Breco Research Inc.
Houston, Texas, 77024, United States
'Diabetes Center of the Southwest
Midland, Texas, 79705, United States
'Diabetes & Glandular Disease Research Associates, P.A.
San Antonio, Texas, 78229, United States
'Radiant Research San Antonio
San Antonio, Texas, 78229, United States
'Salt Lake Women's Center
Sandy City, Utah, 84070, United States
'Fletcher Allan Health Center, UHC Campus 1
Burlington, Vermont, 05401, United States
'Center for Arthritis and Diabetes
Newport News, Virginia, 23606, United States
'National Clinical Research, Inc.
Richmond, Virginia, 23294, United States
'MCV Physicians Program for Osteoporosis
Richmond, Virginia, 23298, United States
'South Puget Sound Clinical Research Center
Olympia, Washington, 98502, United States
Phillip J. Mease
Seattle, Washington, 98104, United States
'Osteoporosis Research Group
Seattle, Washington, 98105, United States
'University of Wisconsin Medical Foundation
Madison, Wisconsin, 53792, United States
'Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
'IDIM
Buenos Aires, BUE, C1012AAR, Argentina
'Centro Médico T.I.E.M.P.O
Buenos Aires, BUE, C1117ABH, Argentina
'Hospital Ramos Mejía
Buenos Aires, BUE, C1221ADC, Argentina
'Centro de Osteopatias Medicas
Capital Federal, CBA, C1114AAI, Argentina
'Universidade Federal do Paraná
Curitiba, Paraná, 80060, Brazil
'Universidade Federal de Pernambuco
Recife, Pernambuco, 50670, Brazil
'Hospital Santa Casa de Misericórdia do Rio de Janeiro
Rio de Janeiro, Rio de Janeiro, 20020, Brazil
'Hospital do Servidor Público do Rio de Janeiro
Rio de Janeiro, Rio de Janeiro, 20221, Brazil
'UNICAMP
Campinas, São Paulo, 13083, Brazil
'Pontifícia Universidade Católica de Campinas
Campinas, São Paulo, Brazil
'Hospital Santa Casa de Misericórdia de São Paulo
São Paulo, São Paulo, 01221, Brazil
'Universidade Federal de São Paulo
São Paulo, São Paulo, 04038, Brazil
'Instituto de Saúde e Bem Estar da Mulher
São Paulo, São Paulo, 04062, Brazil
'Hospital Heliópolis
São Paulo, São Paulo, 04231, Brazil
'Multifunctional Hospital for Active Treatment "Sv.Georgy"
Plovdiv, 4002, Bulgaria
'SHATENG"Acad.Ivan Penchev"
Sofia, 1303, Bulgaria
'Multifunctional Hospital for Active Treatment "Alexandrovska
Sofia, 1431, Bulgaria
'Multifunctional Hospital for Active Treatment "Sv.Ivan Rilsky"
Sofia, 1431, Bulgaria
'SHATGO"Sheynovo"
Sofia, 1504, Bulgaria
'Heritage Medical Research Clinic
Calgary, Alberta, 'T2N 4N1, Canada
Osteoporosis Research Center
Vancouver, British Columbia, V5Z 2N6, Canada
'Manitoba Clinic
Winnipeg, Manitoba, 'R3A 1M3, Canada
Charlton Medical Centre
Hamilton, Ontario, L8N 1Y2, Canada
Rafat Faraawi
Kitchener, Ontario, N2M 5N6, Canada
'Centre for Activity and Aging
London, Ontario, 'N6G 2M3, Canada
St. Joseph's Health Centre
London, Ontario, N6A 4V2, Canada
'Royal Victoria Hospital
Montreal, Ontario, 'H3A 1A1, Canada
Oakville Bone Center
Oakville, Ontario, L6J 1X8, Canada
Ottawa Hospital
Ottawa, Ontario, 'K1H 8L6, Canada
'Sunnybrook and Women's College Health Science Center
Toronto, Ontario, 'M4N 3M5, Canada
'St. Michael's Hospital
Toronto, Ontario, 'M5C 2T2, Canada
'Osteoporosis Research Program
Toronto, Ontario, 'M5S 1B2, Canada
Jude F. Rodrigues
Windsor, Ontario, N8W 5L7, Canada
'Riverside Medical Centre
Charlottetown, Prince Edward Island, C1A 6A4, Canada
'Complexe Hospitalier de la Sagami
Chicoutimi, Quebec, G7H 5H6, Canada
'Centre d'Etude Clinique Montreal Inc.
Montreal, Quebec, 'H1T 1P6, Canada
'Hopital Maisonneuve-Rosemont
Montreal, Quebec, 'H1T 2M4, Canada
'Centre de Recherche du CHUM - Hopital Saint-Luc
Montreal, Quebec, 'H2X 1P1, Canada
Centre de Recherche - CORQ
Sainte-Foy, Quebec, G1V 3M7, Canada
Novabyss Research Clinic
Sherbrooke, Quebec, J1J 2B8, Canada
'Saskatoon Osteoporosis Centre
Saskatoon, Saskatchewan, 'S7K 0H6, Canada
'Soroka Medical Center
Beersheba, 84101, Israel
'Clalit Health Services
Beersheba, 84894, Israel
'Hillel Yaffe Medical Center
Hadera, 38101, Israel
'Rambam Medical Center
Haifa, 31096, Israel
'Lin Medical Center
Haifa, 34162, Israel
'Hadassah University Hospital
Jerusalem, 91240, Israel
'Rabin Medical Center
Petah Tikva, 49100, Israel
'Chaim Sheba Medical Center
Ramat Gan, 52621, Israel
'Lis Maternity Hospital
Tel Aviv, Israel
'Hospital Clinical del Parque
Chihuahua City, CHIH, 31020, Mexico
'Hospital Angeles de las Lomas
Huixquilucan, EMEX, 52763, Mexico
'Hospital Aranda de la Parra
León, Guanajuato, 37000, Mexico
'OPD Hospital Civil de Guadalajara Dr. Juan I. Menchaca
Guadalajara, Jalisco, 44340, Mexico
'Hospital Civil de Belem
Guadalajara, Jalisco, 44650, Mexico
'Medica Monraz
Guadalajara, Jalisco, 44670, Mexico
'Osteosol
Mexico City, Mexico City, 06100, Mexico
'Instituto Mexicano de Investigacion Clinica
Mexico City, Mexico City, 06700, Mexico
'Hospital de Mexico
Mexico City, Mexico City, 11800, Mexico
'Hospital Central "Ignacio Morones Prieto"
San Luis Potosí City, San Luis Potosí, 78240, Mexico
'Hospital Universitario de Monterrey
Monterrey Nuevo Leon, 64040, Mexico
'CLINTRIAL "DORIS" Medical Centre
Bucharest, 772021, Romania
'Centrul Medical Sabyc
Bucharest, Romania
'Spitalul Clinic Judetean Cluj-Napoca
Cluj-Napoca, 3400, Romania
'Scientific Center of Endocrinology of RAMS
Moscow, 117036, Russia
'JK "Medicine"
Moscow, 125047, Russia
'Russian Academy for Advanced Medical Studies
Moscow, 125315, Russia
Related Publications (1)
Greenspan SL, Bone HG, Ettinger MP, Hanley DA, Lindsay R, Zanchetta JR, Blosch CM, Mathisen AL, Morris SA, Marriott TB; Treatment of Osteoporosis with Parathyroid Hormone Study Group. Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann Intern Med. 2007 Mar 6;146(5):326-39. doi: 10.7326/0003-4819-146-5-200703060-00005.
PMID: 17339618DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Study Director
Takeda
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 9, 2005
First Posted
September 15, 2005
Study Start
April 27, 2000
Primary Completion
November 7, 2003
Study Completion
November 7, 2003
Last Updated
May 14, 2021
Record last verified: 2021-05